APLP2 and pancreatic neoplasm: We had previously shown that inducible knockdown of APLP2 (via shRNA) was able to delay tumor development, reduce tumor burden, and decrease metastases to the diaphragm, kidney, and intestine in an orthotopic implantation model of pancreatic cancer [10].